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be excited from a single light source. Due to their superior properties, QDs are a promising fluorophores for 
development of diagnostic labels based on conjugates of QDs with capture biomolecules, which may be used for 
simultaneous multiplexed labeling (Zrazhevskiy and Gao (2013)) and ultrasensitive detection of specific biological 




CEA carcinoembryonic antigen 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
HER2 human epidermal growth factor receptor 2 
PMPI p-maleimidophenyl isocyanate 
QDs quantum dots  
SMCC succinimidyl trans-4-(maleimidylmethyl)cyclohexane-1-carboxylate 
SdAbs single-domain antibodies 
 
In clinic, the development of new methods for more sensitive detection of tumor-associated biomarkers is one of 
cutting-edge lines of research. For this reason, special attention is paid to novel diagnostic probes with high 
specificity and sensitivity for cancer biomarkers that could be used for detection, imaging, and medical diagnostics. 
For target detection, QDs are conjugated with capture molecules, such as antibodies (Abs) (Montenegro et al. 
(2013) ; peptides (Chen et al. (2014)), proteins (Ag et al. (2014)), and oligonucleotides (Zhang et al. (2013)). IgG 
Abs conjugated to QDs have been successfully used for immunofluorescent labeling of cell-surface receptors in cell 
suspensions and tissues (Yang et al. (2011); Rizvi et al. (2014)). However, a comparatively large size of the 
conjugates may result in poor penetration into tissues and impede access to the epitopes. Some smaller Ab fragments 
retaining the functional activity of full-size Abs have been conjugated to QDs in order to produce a probe with 
smaller sizes (Mahmoud et al. (2011); Sukhanova et al. (2011)). Single-domain Abs (sdAbs), also referred to as 
nanobodies, are the smallest known antigen-recognizing molecules. They are derived from llama heavy-chain Abs. 
SdAbs are about 12 times smaller than full-size Abs, while preserving about the same affinity for antigens (Fig. 1B). 
We have developed (Sukhanova et al. (2012a)) and described in detail (Sukhanova et al. (2012b)) a protocol for 
conjugation of sdAbs with QDs in a highly oriented manner, resulting in very bright and compact conjugates, with 
all antigen-binding sites oriented towards the outside of the conjugate. The resultant diagnostic probes have been 
used for highly sensitive detection of tumor-associated antigens on the cell surface. 
 
2. Materials and methods 
2.1 Preparation of water-soluble quantum dots 
QDs were synthesized as described in (Wargnier et al. (2004)), their surface properties were analyzed using an 
FTIR-8400S Fourier transform infrared spectrophotometer (Shimadzu). Then, the QDs were solubilized and 
stabilized in aqueous buffer solutions as described in (Sukhanova et al. (2012); Stsiapura et al. (2006)). Briefly, at 
the first stage, the QD surface was modified with DL-cysteine. At the next stage, the surface was modified with 
polyethylene glycol derivatives containing terminal thiol, hydroxyl, or amino groups. As a result, stable water-
soluble populations of QDs with different surface compositions were obtained. 
2.2 Preparation of conjugates containing quantum dots and partly reduced antibody fragments 
Conjugates of quantum dots and full-size Ab fragments were prepared as described in (Mahmoud et al. (2011)). 
Full-size Abs were partly reduced using 2-mercaptoethanol-amine-HCl or low concentrations of dithiothreitol, 
which resulted in a high yield of functionally active 75-kDa fragments. Then, the fragments were conjugated with 
QDs using the succinimidyl trans-4-(maleimidylmethyl)cyclohexane-1-carboxylate crosslinker (SMCC) in an 
oriented manner to ensure functional activity of the conjugates. Briefly, QDs were activated with SMCC for 1 h; 
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3.  Results and discussion 
3.1 Preparation of conjugates of quantum dots with antibodies 
A number of effective approaches have been proposed to bind the Ab molecules to the QD surface (Bilan et al. 
(2015)). The methods include covalent coupling and electrostatic interactions; highly specific interactions (such as 
between biotin and streptavidin) have proved to be effective. 
The most widely used method of covalent conjugation is based on carbodiimide-mediated coupling of primary 
amines to activated carboxylic acid groups. The water-soluble 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC) is used to activate carboxylic groups, generating a reactive intermediate that rapidly interacts with amines to 
form covalent amide bonds. Since the Ab molecule contains at least one amine and one carboxylic group, the 
method can be easily applied to almost any Ab without its preliminary chemical modifications. The conjugation 
proceeds randomly, which may result in undesirable cross-linking and reduction of the functional activity of the 
Abs. Hence, accurate selection of optimal conjugation parameters is required to produce the most biologically active 
product (East et al. (2011)). 
Another approach to covalent conjugation, which is employed in a commercially available conjugation kit 
(Invitrogen), is based on reduction of disulfide bonds in full-size Abs (with a molecular weight of 150 kDa) using 
dithiothreitol, which results in three types of fragments with different molecular weights: light chain (25 kDa), 
heavy chain (50 kDa), and partially cleaved heavy–light chain (75 kDa) fragments, with only the 75-kDa heavy–
light chain fragments retaining the functional activity, because they have intact antigen binding sites. The mixture of 
fragments was covalently attached to the QDs surface, resulting in conjugates with a functional activity strongly 
limited by the number of active heavy–light chain fragments in a nanoprobe. Indeed, the number of functional Abs 
in the commercial QD–Ab conjugates prepared according to this approach turned out to be as low as 0.076 ± 0.014 
Abs/QD (Pathak et al. (2007)). In our previous study (Mahmoud et al. (2011)), we have improved the procedure for 
partial reduction of Abs, which allows the disulfide bonds between heavy and light chains to remain intact, while the 
disulfide bonds between heavy chains are reduced, resulting in a high yield of functionally active 75-kDa fragments. 
These active fragments were conjugated to the QDs in an oriented manner, with a preserved functional activity of 
the conjugate. The prepared conjugate was found to be 26 times more sensitive than the conjugate prepared from the 
Abs reduced according to the standard protocol. 
Oriented conjugation of Abs with nanoparticles is known to improve the specificity of the resultant probe in 
comparison to random conjugation using carbodiimide chemistry (Puertas et al. (2011)). In our previous studies, we 
developed oriented conjugates of QDs and sdAbs, the smallest possible naturally occurring antigen-binding 
fragments known, with a molecular weight of about 13 kDa. Due to their compact size, sdAbs diffuse in tissues 
much better than full-size Abs and may bind sterically hindered epitopes, such as cavities (Perruchini et al. (2009)). 
Having the same affinity and about the same variability as full-size Abs, sdAbs exhibit a low immunogenicity, as 
well as better stability and capability of refolding after denaturation, which makes these Abs promising components 
for the development of specific fluorescently labeled probes. 
In our study, sdAbs were modified with an additional cysteine residue specifically integrated into the C-terminal 
end of the sdAb amino acid sequence, far away from the antigen-binding site. SdAbs were covalently conjugated to 
QDs through the SH group of the cysteine residue, which resulted in highly oriented conjugates, with all antigen-
binding sites oriented to the outside of the probe (Sukhanova et al. (2012a)) (Fig. 1B). The resultant compact probes 
had a hydrodynamic diameter below 12 nm and contained four molecules of sdAbs on the surface of each QD. The 
conjugates turned to be promising probes for immunolabeling of several biomarkers in cells and tissue specimens. 
3.2 Conjugates of single-domain antibodies and quantum dots for ultrasensitive detection of tumor-associated 
biomarkers 
In a series of our studies, we used oriented sdAb–QD conjugates for detection cell-surface cancer biomarkers in 
live cells and tissue specimens. We have demonstrated that the sdAb–QD conjugates can specifically bind CEA, cell 
surface receptor expressed by many types human tumor cells. The conjugates proved to be good candidates for 
immunohistochemical analysis of thick tissues: sdAbs–QD stained CEA in a more delicate manner than full-size 
Abs and lead to biopsy tissue labeling of an equivalent or even better quality than that obtained with “gold standard” 
immunohistochemical labeling of tissue sections with diaminobenzidine (Sukhanova et al. (2012a)). 
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the tissues, which allow the detection of sdAb–QD conjugates more than three times deeper in tissue sections (26 
μm) than it is possible using single-photon excitation (8 μm). Thus, sdAb–QD conjugates have proved to be a 
superior alternative to conjugates of conventional organic dyes in their application to imaging biomarkers in 
biological fluids and tissue sections displaying intense autofluorescence. We suppose that the conjugates developed 
are useful for detecting low concentrations of antigens and for tracking cells deep within tissues by means of 
multiphoton microscopy. Table 1 summarizes the most interesting prospects for future applications and further 
development of the conjugates described. 
Table 1. Prospects for future applications and further developments of the sdAb–QD conjugates. 
In vitro applications In vivo applications Bioanalytical assays Combined imaging 
techniques 
Membrane receptor labeling Tumor detection and 
diagnostics 
Fluorescent staining in ELISA 
Planar microarrays 
Epifluorescent, single- and 
miltiphoton microscopies 
Intracellular labeling Single-cell tracking Suspension microarrays Fluorescence lifetime imaging 
microscopy 
Single molecule tracking Photodynamic therapy Cell sorting Ultrahigh-resolution imaging 
 
4. Conclusions 
Compact highly oriented sdAb–QD conjugates is a superior alternative to conjugates of conventional organic 
dyes traditionally used as diagnostic probes and to commercially available conjugates of QDs with conventional 
full-size Abs. These novel nanoprobes have proved to be particularly efficient for detection of the cell-surface 
cancer biomarkers CEA and HER2 both on live cells and on fixed tissue specimens. Due to unique spectral 
properties of QDs in combination with high specificity of compact sdAbs, it is possible to detect small quantities of 
CEA-positive cells in a mixture with CEA-negative cells by means of flow cytometry. Immunohistochemical 
staining of thick tissues with sdAb–QD probes display the same or even better quality than that obtained with the 
“gold standard” immunohistochemical labeling used in clinical analysis. Since QDs are characterized by the highest 
values of two-photon absorption cross-sections, promising prospects are opened for sdAb–QD applications in 
multiphoton microscopy for deep tissue imaging and highly sensitive detection of low concentrations of antigens. 
We believe that the approach described here will be a great stride towards highly sensitive multiplexed detection of 
numerous of biomarkers for precise clinical analysis. 
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